Direct Oral Anticoagulants Market Size to Reach USD 102.12 Bn by 2034

The global direct oral anticoagulants (DOACs) market was valued at USD 47.30 billion in 2024 and is projected to reach around USD 102.12 billion by 2034, growing at a CAGR of 8%. Growth is driven by rising thromboembolic disorder cases and improved drug efficacy.

Direct Oral Anticoagulants (DOACs) Market

Direct Oral Anticoagulants (DOACs) Market Statical Scope

Reports Attributes	Statistics
Market Size in 2024	USD 47.30 Billion
Market Size in 2025	USD 51.09 Billion
Market Size in 2031	USD 81.07 Billion
Market Size by 2034	USD 102.12 Billion
CAGR 2025 to 2034	8%
Base Year	2024
Forecast Period	2025 to 2034

What is Oral Antiseptics Market Size in 2024 to 2034?

The global oral antiseptics market was valued at USD 2.82 billion in 2024 and is expected to reach nearly USD 4.51 billion by 2034, growing at a steady CAGR of 4.8%. Demand is driven by infection prevention, dental hygiene awareness, and expanding healthcare protocols.

Oral Antiseptics Market

What is Oral Syringes Market Size in 2024 to 2034?

The global oral syringes market, valued at USD 742.52 million in 2024, is forecast to reach USD 1,355.04 million by 2034, expanding at a CAGR of 6.20%. The market growth is driven by increasing demand in healthcare settings and homecare environments.

Oral Syringes Market

Direct Oral Anticoagulants (DOACs) Market Companies:

Bristol Myers Squibb
Pfizer
Daiichi Sankyo
Janssen Pharmaceutic
Bayer
Viat
Boehringer Ingelheim
Accord Healthcare
Sandoz
Teva Pharmaceutical
My
Apotex
GlaxoSmithKline

Direct Oral Anticoagulants (DOACs) Market Segmentation:

By Type

Oral Factor Xa Inhibitors
Direct Thrombin Inhibitors (DTIs)

By Application

Deep Vein Thrombosis
Pulmonary Embolism
Atrial Fibrillation
Other

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Global Market Size

Direct Oral Anticoagulants (DOACs) Market Size By Region 2025 to 2034 (USD Billion)

Region	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
North America	17.97	19.26	20.63	22.11	23.68	25.37	27.17	29.10	31.17	33.38	35.74
Asia Pacific	14.19	15.68	17.32	19.13	21.11	23.28	25.67	28.29	31.17	34.32	37.78
Europe	11.83	12.62	13.46	14.36	15.32	16.33	17.41	18.56	19.79	21.09	22.47
LAMEA	3.31	3.52	3.75	3.99	4.25	4.52	4.80	5.11	5.43	5.77	6.13

Direct Oral Anticoagulants (DOACs) Market Size By Type 2025 to 2034 (USD Billion)

Type	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Oral Factor Xa Inhibitors	34.06	36.98	40.16	43.62	47.36	51.43	55.84	60.64	65.84	71.48	77.61
Direct Thrombin Inhibitors (DTIs)	13.24	14.10	15.01	15.97	16.99	18.07	19.22	20.43	21.71	23.07	24.51

Direct Oral Anticoagulants (DOACs) Market Size By Application 2025 to 2034 (USD Billion)

Application	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Atrial Fibrillation	18.92	20.64	22.51	24.55	26.77	29.19	31.83	34.70	37.82	41.23	44.93
Deep Vein Thrombosis	11.83	12.62	13.46	14.36	15.32	16.33	17.41	18.56	19.79	21.09	22.47
Pulmonary Embolism	9.46	10.22	11.03	11.92	12.87	13.90	15.01	16.21	17.51	18.91	20.42
Other	7.10	7.61	8.17	8.76	9.40	10.08	10.81	11.59	12.43	13.33	14.30

List of Table and Figure

List of Tables

Table 1: North America Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 2: North America Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 3: U.S. Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 4: U.S. Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 5: Canada Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 6: Canada Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 7: Mexico Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 8: Mexico Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 9: Europe Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 10: Europe Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 11: Germany Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 12: Germany Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 13: U.K. Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 14: U.K. Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 15: France Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 16: France Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 17: Italy Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 18: Italy Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 19: Rest of Europe Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 20: Rest of Europe Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 21: Asia-Pacific Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 22: Asia-Pacific Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 23: China Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 24: China Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 25: Japan Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 26: Japan Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 27: India Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 28: India Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 29: South Korea Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 30: South Korea Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 31: Southeast Asia Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 32: Southeast Asia Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 33: Latin America Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 34: Latin America Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 35: Brazil Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 36: Brazil Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 37: Rest of Latin America Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 38: Rest of Latin America Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 39: Middle East & Africa Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 40: Middle East & Africa Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 41: GCC Countries Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 42: GCC Countries Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 43: Turkey Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 44: Turkey Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)
Table 45: Africa Direct Oral Anticoagulants (DOACs) Market Size, by Type, 2024–2034 (USD Billion)
Table 46: Africa Direct Oral Anticoagulants (DOACs) Market Size, by Application, 2024–2034 (USD Billion)

List of Figures

Figure 1: Direct Oral Anticoagulants (DOACs) Market Share, by Type, 2024 (%)
Figure 2: Direct Oral Anticoagulants (DOACs) Market Share, by Application, 2024 (%)
Figure 3: Global Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 4: North America Direct Oral Anticoagulants (DOACs) Market Share, by Country, 2024 (%)
Figure 5: Europe Direct Oral Anticoagulants (DOACs) Market Share, by Country, 2024 (%)
Figure 6: Asia-Pacific Direct Oral Anticoagulants (DOACs) Market Share, by Country, 2024 (%)
Figure 7: Latin America Direct Oral Anticoagulants (DOACs) Market Share, by Country, 2024 (%)
Figure 8: Middle East & Africa Direct Oral Anticoagulants (DOACs) Market Share, by Country, 2024 (%)
Figure 9: U.S. Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 10: Canada Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 11: Mexico Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 12: Germany Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 13: U.K. Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 14: France Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 15: Italy Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 16: China Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 17: Japan Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 18: India Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 19: South Korea Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 20: Brazil Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 21: GCC Countries Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 22: South Africa Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 23: Turkey Direct Oral Anticoagulants (DOACs) Market Forecast, 2024–2034 (USD Billion)
Figure 24: Global Direct Oral Anticoagulants (DOACs) Competitive Landscape, 2024 (%)

Author
Recent Posts

Rohan Patil

Principal Research Analyst | Towards Dental
Rohan Patil stands at the forefront of dental market research, leveraging over five years of specialized experience to navigate the intricate landscape of the global dental industry. As Principal Research Analyst at Towards Dental, he spearheads comprehensive research initiatives that encompass a broad spectrum of dental sectors, including orthodontics, periodontics, prosthodontics, and endodontics.

At Towards Dental, Rohan's expertise extends to analyzing emerging trends in dental technologies, regulatory frameworks, and market dynamics. He is instrumental in assessing the adoption of digital dentistry, advancements in dental materials, and the integration of artificial intelligence in diagnostic and treatment modalities.
Rohan's analytical acumen is complemented by his proficiency in translating complex data into actionable insights, enabling him to provide strategic recommendations that inform decision-making across the dental industry. His work not only supports dental professionals and organizations but also contributes to shaping the future trajectory of dental care globally. A trusted advisor and relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving dental landscape.